BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
✅
( ) Vol: Issue Pages: Pub: 2021 Sep Epub: Authors Embleton N , Berrington J , Cummings S , Dorling J , Ewer A , Frau A , Juszczak E , Kirby J , Lamb C , Lanyon C , Lett L , McGuire W , Probert C , Rushton S , Shirley M , Stewart C , Young GR , |
|
|
Oral Lactoferrin Supplementation during Induction Chemotherapy Promotes Gut Microbiome Eubiosis in Pediatric Patients with Hematologic Malignancies. ✅
Go to Publication ✅
Pharmaceutics (Pharmaceutics ) Vol: 14 Issue 8 Pages: Pub: 2022 Aug 16 Epub: 2022 Aug 16 Authors D'Amico F , Decembrino N , Muratore E , Turroni S , Muggeo P , Mura R , Perruccio K , Vitale V , Zecca M , Prete A , Venturelli F , Leardini D , Brigidi P , Masetti R , Cesaro S , Zama D , |
|
|
Treatment of lactoferrin and antimicrobial peptide N6 on bacterial enteritis caused by Escherichia coli in mice. ✅
Go to Publication ✅
Biochemistry and cell biology = Biochimie et biologie cellulaire (Biochem Cell Biol ) Vol: 103 Issue Pages: 1-12 Pub: 2025 Jan 1 Epub: 2024 Oct 11 Authors Ma X , Zhang K , Yang N , Hao Y , Mao R , Teng D , Wang J , |
|
|
Correction: Optimal dose of lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 19 Issue 8 Pages: e0307969 Pub: 2024 Epub: 2024 Aug 22 Authors Hussan JR , Irwin S , Matthews BG , Swift S , Williams DL , Cornish J , |
|
|
Correction: Optimal dose of lactoferrin reduces the resilience of in vitro Staphylococcus aureus colonies. ✅
Go to Publication ✅
PloS one (PLoS One ) Vol: 19 Issue 8 Pages: e0307969 Pub: 2024 Epub: 2024 Aug 22 Authors Hussan JR , Irwin S , Matthews BG , Swift S , Williams DL , Cornish J , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
